Abstract Library

#1456 Retreatment with Peptide-Receptor Radionuclide Therapy: Effects on Long-term Survival, Renal and Bone Marrow Toxicity Using Yttrium-90 vs. Lutetium-177

Introduction: PRRT is an effective treatment for metastatic NETs. The effect of PRRT retreatment is unknown.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Machta J

Authors: Machta J, Caplin M, Toumpanakis C, Mohmaduvesh M, Garcia-Hernandez J,

Keywords: PRRT, retreatment,

#1242 Epidemiological Characteristics from a Single Centre Database. Cohort of 1301 Neuroendocrine Tumor Patients: Is There an Association Between Age and Grade of NET?

Introduction: There is limited data related to epidemiology of NETs and patient survival. For many cancers younger age of diagnosis can be associated with worse survival.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Garcia-Hernandez J, Mohmaduvesh M, Toumpanakis C, Caplin M,

Keywords: Survival,

#1152 Appendiceal Neuroendocrine Tumor: Correlation Between Histopathological Factors

Introduction: Neuroendocrine tumours (NET) of the appendix are rare histopathological neoplasm’s detected following operation for appendicitis. Clinical decisions focuses on different pathological factors for further management. With the aim of defining contemporary patterns of care in surgical practice, a critical review of the records is carried to establish a correlation between different histopathological parameters

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Nada H

Authors: Nada H, Anania M, Luong T, Garcia-Hernandez J, Caplin M,

Keywords: Appendicectomy, Appendix, Carcinoid tumour(s), Neuroendocrine tumors,

#1146 Somatostatin Analogues in Bronchial Neuroendocrine Tumors: Symptom Control and Anti-Proliferative Role

Introduction: There is no established fist-line medical treatment for advanced bronchial NETs.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Efthimia K

Authors: Karra E, Polycarpou A, Tanaskovic N, Garcia-Hernandez J, Mullan M,

Keywords: Bronchial NET,

#872 Urinary 5-hydroxyindoleacetic Acid In Serotonin-Producing Neuroendocrine Tumors: Correlation with Disease Features and Patients' Survival

Introduction: Urinary 5-hydroxyindoleacetic acid (U-5HIAA) is a useful marker for serotonin-producing neuroendocrine tumors (NETs). Its prognostic role, however, is yet to be fully elucidated.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Bartholomew T, Garcia-Hernandez J, Rossi R, Braude D, Mullan M,

Keywords: U-5HIAA, symptoms, prognosis, survival,